Evidence map›Paper›PMID 41465975›Full record

ArticleMedicine2025

Formulation principles and mechanisms of TCM patent prescriptions for PCOS: A data mining study from CNIPA.

Na Shi, Shuhua Ji, Yan Zhang, Huiling Qu, Jinwei Hou, Longhuan Jiang, Haiping Liu

Abstract read
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Na ShiDepartment of Reproductive Medicine, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, China.ORCID 0000-0003-1564-2236
Shuhua Ji
Yan Zhang
Huiling Qu
Jinwei Hou
Longhuan Jiang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study applied data mining and network pharmacology to investigate the formulation principles and potential mechanisms of Traditional Chinese Medicine (TCM) patent prescriptions for treating polycystic ovary syndrome (PCOS) in China, offering insights for effective clinical application and providing the foothold for further drug research and development. All TCM patent prescriptions targeting PCOS were extracted from the China National Intellectual Property Administration website. Data analysis, clustering, and association rules were performed using SPSS and IBM SPSS Modeler. A core herb-drug network was visualized with Cytoscape. Active ingredients and targets of new TCM prescriptions were collected, with disease-related targets being identified through pertinent databases. Further Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were analyzed via Database for Annotation, Visualization and Integrated Discovery. Seventy-Eight prescriptions met the inclusion criteria and were included in the analysis (2007-2024), containing 320 distinct herbs. The 5 most frequently used single herbs were Cuscuta chinensis Lam., Angelica sinensis (Oliv.) Diels, Cyperus rotundus L., Salvia miltiorrhiza Bunge and Rehmannia glutinosa (Gaertn.) Libosch. ex Fisch. & C.A. Mey. Prominent herbal pairs and triples were identified. Herbs with high frequency were primarily assigned to the liver, kidney, and spleen meridians. They were characterized by warm and plain properties, predominantly displaying bitter and sweet flavors. The clustering analysis yielded 5 novel TCM prescriptions (C1-C5) with specific clinical relevance for PCOS. Potential mechanisms were explored through drug-disease target intersections and KEGG pathways analysis was revealed. TCM patent prescriptions for PCOS were based on "tonifying the kidney, invigorating the spleen, and smoothing the liver" for fundamental care, and "regulating qi, resolving phlegm, and removing dampness," "activating blood circulation and dissolving blood stasis," and "softening hardness to disperse stagnation" for symptomatic relief. Data mining suggests potential mechanisms and therapeutic pathways that may underpin efficacy, primarily through pathways related to lipid and atherosclerosis, NF-kappa B, AGE-RAGE, Estrogen, FoxO, p53, and TNF signaling pathway. This study established a reference point for the clinical management of PCOS. Offering valuable guidance for clinical practice and laying a preliminary foundation for developing new therapeutic interventions.

Indexed as

Drugs, Chinese HerbalMedicine, Chinese TraditionalPolycystic Ovary SyndromeChinaData MiningDrug PrescriptionsFemaleHumansNetwork PharmacologyDrugs, Chinese Herbaldata miningformulation principlesmechanismnetwork pharmacologypolycystic ovary syndromeTCM patent prescription

Identifiers

PMID41465975
PMCPMC12746980

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.